News

  • 6 December 2018

    Eisai and UCL deepen drug discovery alliance

    Japanese pharmaceutical company Eisai has expanded its drug discovery collaboration with University College London (UCL) in the UK for additional five years to 2023.

  • 5 December 2018

    UCB to invest £1bn in the UK Life Sciences Sector Deal

    Belgian biopharmaceutical company UCB has agreed to invest approximately £1bn ($1.27bn) as part of a collaboration between the UK government and life sciences industry intended to support healthcare innovation in...